Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Demeditec Diagnostics is a private German in vitro diagnostics company that manufactures and supplies diagnostic test kits for clinical laboratories and research customers worldwide. Its portfolio includes radioactive and non-radioactive immunoassays, including RIA, IRMA, ELISA, rapid tests, and selected LC-MS/MS reagents, with applications spanning endocrinology, salivary diagnostics, infectious disease, autoimmunity, tumor markers, veterinary diagnostics, and food analytics. The company operates R&D and in-house production in Kiel, Germany, and states that it distributes into more than 80 countries. Demeditec appears to be a commercial-stage diagnostics supplier rather than a therapeutics developer, with revenues generated from catalog products and distribution. A notable recent product in its portfolio is EndomKIT, a CE-marked in vitro diagnostic for aiding endometriosis diagnosis based on BDNF, CA125, and clinical variables.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Demeditec Diagnostics.